Diaceutics PLC

OTCPK:DIUX.F Stock Report

Market Cap: US$162.3m

Diaceutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:DIUX.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Mar 26BuyUS$198Susanne MunkstedIndividual99US$2.00
02 Mar 26BuyUS$200Jordan ClarkIndividual100US$2.00
02 Mar 26BuyUS$200Nicholas RobertsIndividual100US$2.00
23 Dec 25BuyUS$202Jordan ClarkIndividual117US$1.73
23 Dec 25BuyUS$202Susanne MunkstedIndividual117US$1.73
23 Dec 25BuyUS$202Jillian BeggsIndividual117US$1.73
23 Dec 25BuyUS$202Nicholas RobertsIndividual117US$1.73
28 Nov 25BuyUS$200Jordan ClarkIndividual95US$2.10
28 Nov 25BuyUS$200Susanne MunkstedIndividual95US$2.10
28 Nov 25BuyUS$200Jillian BeggsIndividual95US$2.10
28 Nov 25BuyUS$200Nicholas RobertsIndividual95US$2.10
03 Nov 25BuyUS$196Jordan ClarkIndividual92US$2.13
03 Nov 25BuyUS$200Susanne MunkstedIndividual94US$2.13
03 Nov 25BuyUS$196Jillian BeggsIndividual92US$2.13
03 Nov 25BuyUS$196Nicholas RobertsIndividual92US$2.13
01 Oct 25BuyUS$202Jordan ClarkIndividual91US$2.22
01 Oct 25BuyUS$202Susanne MunkstedIndividual91US$2.22
01 Oct 25BuyUS$202Jillian BeggsIndividual91US$2.22
01 Oct 25BuyUS$202Nicholas RobertsIndividual91US$2.22
01 Sep 25BuyUS$203Jordan ClarkIndividual107US$1.90
01 Sep 25BuyUS$203Susanne MunkstedIndividual107US$1.90
01 Sep 25BuyUS$203Jillian BeggsIndividual107US$1.90
01 Sep 25BuyUS$203Nicholas RobertsIndividual107US$1.90
29 Jul 25BuyUS$200Jordan ClarkIndividual111US$1.80
29 Jul 25BuyUS$200Susanne MunkstedIndividual111US$1.80
29 Jul 25BuyUS$200Jillian BeggsIndividual111US$1.80
29 Jul 25BuyUS$200Nicholas RobertsIndividual111US$1.80

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DIUX.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies97,2020.115%
Public Companies172,7470.204%
State or Government877,1921.04%
General Public8,753,79810.3%
VC/PE Firms15,185,52717.9%
Individual Insiders19,650,60623.2%
Institutions39,933,14847.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 83.05% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18%
Peter Keeling
15,252,049US$29.2m0%no data
17.9%
Gresham House Asset Management Limited
15,185,527US$29.1m0%no data
6.22%
Canaccord Genuity Asset Management Limited
5,264,000US$10.1m-2.32%no data
3.53%
Ryan Keeling
2,990,643US$5.7m0%no data
3.22%
Aberdeen Group Plc
2,727,548US$5.2m-1.28%no data
3%
West Elk Capital, LLC
2,543,281US$4.9m0%no data
2.91%
BlackRock, Inc.
2,461,608US$4.7m-0.96%no data
2.87%
Octopus Investments Limited
2,426,968US$4.7m0%no data
2.74%
River Global Investors LLP
2,321,749US$4.5m18.6%no data
2.58%
Maven Capital Partners UK LLP
2,187,000US$4.2m-11.5%no data
2.43%
TrinityBridge Limited
2,055,575US$3.9m149%no data
1.94%
AXA Investment Managers S.A.
1,646,144US$3.2m39.4%no data
1.89%
Columbia Management Investment Advisers, LLC
1,598,768US$3.1m0%no data
1.69%
Edentree Asset Management Limited
1,430,500US$2.7m0%no data
1.6%
Danske Capital Denmark
1,357,274US$2.6m-33.3%no data
1.51%
Hargreaves Lansdown Asset Management Ltd.
1,275,719US$2.4m-13.2%no data
1.44%
BNY Mellon Advisors, Inc.
1,219,668US$2.3m-19.1%no data
1.39%
Danske Invest Management A/S
1,180,338US$2.3m-23.1%no data
1.21%
London Wealth Management Limited
1,020,938US$2.0m-3.54%no data
1.04%
Invest Northern Ireland
877,192US$1.7m0%no data
0.92%
Castlefield Investments
781,804US$1.5m6.12%no data
0.85%
Orange River Management LP
723,332US$1.4m-24.3%no data
0.72%
Danske Invest Rahastoyhtio Oy
609,091US$1.2m-6.93%no data
0.71%
Interactive Brokers Group, Inc.
597,366US$1.1m-2.07%no data
0.69%
Jordan Clark
580,383US$1.1m0.02%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/26 21:22
End of Day Share Price 2026/05/28 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Diaceutics PLC is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hayley PalmerCanaccord Genuity
Julie SimmondsPanmure Liberum
Natalia WebsterRBC Capital Markets